Drugs / TIV
last change Dec 2011 re-read 2 minutes ago

TIV

Vaccine

Developed for
influenza
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID) · Stanford University

Trials 1 · a red edge is where a trial was stopped

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03022422 Sep → Dec 2011 influenza Stanford University Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TIV ClinicalTrials.gov intervention name — accepted as the source's own label NCT03022422
Modality Vaccine “seasonal trivalent inactivated influenza vaccineNCT03022422
Route Intramuscular “Influenza Virus Vaccine Suspension for Intramuscular Injection” NCT03022422